STOCK TITAN
  1. Home
  2. News
  3. AKLI
  4. Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET

Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET

Akili, Inc. (NASDAQ: AKLI) will host a conference call on November 10, 2022, at 4:30 p.m. ET to discuss its third-quarter financial results.

Rhea-AI Impact
(High)
Rhea-AI Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Tags
conferences earnings date
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BOSTON--(BUSINESS WIRE)-- Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will host a conference call and webcast to review its third quarter financial results on Thursday, November 10, 2022 at 4:30 p.m. ET.

A live audio webcast of the conference call and presentation will be available at www.akiliinteractive.com under Investor Relations, Events & Presentations. An archived version of the webcast will be available on the company’s website following the event.

To access the call, dial 877-405-1224 (toll-free) or 201-389-0848 (international) and reference “Akili Q3 2022 Earnings”. International toll-free numbers are available here.

About Akili

Akili is pioneering the development of cognitive treatments through game-changing technologies. Our approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com.

Investor:
Joshua Young
VP of Investor Relations
jyoung@akiliinteractive.com

Media:
Julie DiCarlo
SVP, Communications
julie@akiliinteractive.com

Source: Akili, Inc.

Keep reading

More on AKLI

All AKLI news

Trending in the feed

SNDK
Sandisk Reports Fiscal First Quarter 2027 Financial Results Open the live feed
View all latest news